BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
CXCL2
,
T cell receptor signaling pathway
,
Breast Cancer
,
Neuron
,
Alcohol
,
Cisplatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
exon-exon junction complex
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thymus gland
Esophagus
Kidney
Duodenum
Tonsil
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hemorrhagic shock
Multiple-resistant Staphylococcus aureus infection
Obsessive-compulsive disorder
Placental insufficiency
Parvovirus infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
temsirolimus
CP 724714
CGP 60474
ARQ 197
flavopiridol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
lsd-1
INSM2
IRF7
COL7A1
SP110
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
FRET analysis of interactions between actin and exon-exon-junction complex proteins in early mouse e…
Assembly and mobility of exon-exon junction complexes in living cells.
The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in h…
A New Mutation, hap1-2, Reveals a C Terminal Domain Function in AtMago Protein and Its Biological Ef…
A simple whole cell lysate system for in vitro splicing reveals a stepwise assembly of the exon-exon…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Pre…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ